XML 25 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments (Tables)
 9 Months Ended
Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

 

Fiscal year ending September 30,        
2018     $ 34,232  
2019       68,463  
      $ 102,695  
Schedule of purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

 

      Number of Shares     Weighted Average Exercise Price  
Balance, October 1, 2016       1,809,309     $ 2.70  
Exercised       (200,000 )   $ 3.00  
Balance, September 30, 2017       1,609,309     $ 2.66  
Exercised       (18,750 )   $ 1.24  
Balance, June 30, 2018       1,590,559     $ 2.68  
Schedule of exercisable share purchase warrants outstanding

At June 30, 2018, the Company had share purchase warrants outstanding of 1,590,559, with a weighted average exercise price of $2.66 as follows:

 

Number   Exercise Price   Expiry Date
1,262,180   $3.00   July 5, 2018
30,000   $4.00   February 24, 2019
277,127   $1.20   March 13, 2019
1,252   $1.68   March 13, 2019
12,500   $1.24   May 31, 2019
7,500   $1.04   May 31, 2019
1,590,559        
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

      Number of Shares     Weighted Average Exercise Price     Weighted Average Grant Date Fair Value  
Outstanding at October 1, 2016       4,199,000     $ 3.76          
Granted       1,107,500       5.51     $ 5.44  
Forfeited       (214,470 )     4.09          
Outstanding at September 30, 2017       5,092,030       4.13          
Granted       1,930,000       2.98     $ 2.56  
Forfeited       (7,709 )     4.32          
Exercised       (150,833 )     1.18          
Outstanding at June 30, 2018       6,863,488     $ 3.87          
Exercisable at June 30, 2018       3,974,821     $ 3.64          
Exercisable at September 30, 2017       3,326,223     $ 3.10          
Schedule of stock options outstanding

At June 30, 2018, the following stock options were outstanding:

 

Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
  500,000       500,000     $ 1.60     July 5, 2023   $ 510,000       5.01  
  37,500       37,500     $ 1.20     May 7, 2024     53,250       5.85  
  125,000       125,000     $ 1.32     May 8, 2024     162,500       5.86  
  618,750       618,750     $ 0.92     April 2, 2025     1,051,875       6.76  
  29,167       29,167     $ 1.44     June 8, 2025     34,417       6.94  
  50,000       50,000     $ 1.76     June 15, 2025     43,000       6.96  
  265,208       266,250     $ 5.04     September 18, 2025     —       7.22  
  1,500       1,500     $ 5.64     September 30, 2025     —       7.25  
  31,250       28,646     $ 5.68     October 2, 2025     —       7.26  
  25,000       22,916     $ 8.98     October 16, 2025     —       7.30  
  1,500       1,500     $ 5.57     December 31, 2025     —       7.50  
  1,500       1,500     $ 4.90     March 31, 2026     —       7.75  
  1,500       1,500     $ 5.66     April 27, 2026     —       7.82  
  19,697       19,697     $ 4.09     May 18, 2026     —       7.88  
  1,500       1,500     $ 6.11     June 30, 2026     —       8.00  
  379,625       221,448     $ 6.26     July 5, 2026     —       8.01  
  861,429       502,500     $ 7.06     July 18, 2026     —       8.05  
  1,006,696       1,006,696     $ 3.28     September 22, 2026     —       8.23  
  64,166       39,164     $ 3.63     October 3, 2026     —       8.26  
  15,000       8,750     $ 4.35     December 9, 2026     —       8.44  
  50,000       16,667     $ 5.39     February 7, 2027     —       8.61  
  40,000       20,000     $ 5.26     February 17, 2027     —       8.64  
  780,000       325,002     $ 5.92     May 12, 2027     —       8.87  
  12,500       4,167     $ 3.42     August 9, 2027     —       9.11  
  15,000       5,000     $ 4.33     September 19, 2027     —       9.22  
  545,000       90,834     $ 3.30     December 13, 2027     —       9.45  
  50,000       —     $ 2.60     March 2, 2028     1,000       9.67  
  200,000       16,667     $ 2.72     March 19, 2028     —       9.72  
  150,000       12,500     $ 2.30     March 15, 2028     48,000       9.71  
  635,000       —     $ 2.30     March 15, 2028     203,200       9.71  
  350,000       —     $ 4.19     June 18, 2028     —       9.97  
  6,863,488       3,974,821                 $ 2,107,242          
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

 

    Three months ended June 30,     Nine months ended June 30,  
    2018     2017     2018     2017  
General and administrative   $ 802,591     $ 574,470     $ 1,999,633     $ 1,452,181  
Research and development     840,683       585,246       2,025,779       1,565,695  
Total share based compensation   $ 1,643,274     $ 1,159,716     $ 4,025,412     $ 3,017,876  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2018   2017
Risk-free interest rate   2.73%   1.98%
Expected life of options (years)   6.84   6.82
Annualized volatility   108.67%   111.67%
Dividend rate   0.00%   0.00%